Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but we...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-10-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211039135 |
id |
doaj-4862b2224d784d2893d58514bc56e797 |
---|---|
record_format |
Article |
spelling |
doaj-4862b2224d784d2893d58514bc56e7972021-10-09T22:33:28ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-10-012010.1177/15330338211039135Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation TherapySharmi Biswas0Irina Kapitanova1Sabrina Divekar2Jimm Grimm3Ian J. Butterwick4Daniel Garren5Lawrence R. Kleinberg6Kristin J. Redmond7Michel Lacroix8Anand Mahadevan9Kenneth M. Forster10 , New York, NY, USA , New York, NY, USA Sackler School of Medicine, , New York, NY, USA Thomas Jefferson University, Philadelphia, PA, USA , Danville, PA, USA , New York, NY, USA , Baltimore, MD, USA , Baltimore, MD, USA , Danville, PA, USA , Danville, PA, USA , Danville, PA, USAPurpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields.https://doi.org/10.1177/15330338211039135 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sharmi Biswas Irina Kapitanova Sabrina Divekar Jimm Grimm Ian J. Butterwick Daniel Garren Lawrence R. Kleinberg Kristin J. Redmond Michel Lacroix Anand Mahadevan Kenneth M. Forster |
spellingShingle |
Sharmi Biswas Irina Kapitanova Sabrina Divekar Jimm Grimm Ian J. Butterwick Daniel Garren Lawrence R. Kleinberg Kristin J. Redmond Michel Lacroix Anand Mahadevan Kenneth M. Forster Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy Technology in Cancer Research & Treatment |
author_facet |
Sharmi Biswas Irina Kapitanova Sabrina Divekar Jimm Grimm Ian J. Butterwick Daniel Garren Lawrence R. Kleinberg Kristin J. Redmond Michel Lacroix Anand Mahadevan Kenneth M. Forster |
author_sort |
Sharmi Biswas |
title |
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_short |
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_full |
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_fullStr |
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_full_unstemmed |
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_sort |
targeting accuracy considerations for simultaneous tumor treating fields antimitotic therapy during robotic hypofractionated radiation therapy |
publisher |
SAGE Publishing |
series |
Technology in Cancer Research & Treatment |
issn |
1533-0338 |
publishDate |
2021-10-01 |
description |
Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields. |
url |
https://doi.org/10.1177/15330338211039135 |
work_keys_str_mv |
AT sharmibiswas targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT irinakapitanova targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT sabrinadivekar targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT jimmgrimm targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT ianjbutterwick targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT danielgarren targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT lawrencerkleinberg targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT kristinjredmond targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT michellacroix targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT anandmahadevan targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT kennethmforster targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy |
_version_ |
1716830205977296896 |